- Companies
- Evergreen Nephrology
Evergreen Nephrology Funding, Investors & Competitors
Evergreen Nephrology has raised $134M across 2 funding rounds, most recently a $130M undisclosed-stage round in January 2025.
Last Evergreen Nephrology funding round
$130M
Undisclosed stage · Jan 2025
Cumulative funding Evergreen Nephrology raised
$134M
across 2 funding rounds
Key investors in Evergreen Nephrology
Oak HC/FT
K2 HealthVentures
Rubicon Founders
About Evergreen Nephrology
Evergreen Nephrology is a value-based kidney care platform partnering with nephrology practices across the United States. The company supplies clinical operations, data analytics, patient engagement tools, and interdisciplinary teams to manage chronic kidney disease from early stages to dialysis. Headquartered in Nashville, Tennessee, Evergreen Nephrology enables physicians to prioritize high-risk patients through predictive modeling and care coordination services.
Founded
2021
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Services, Subscription
Evergreen Nephrology Funding History
Evergreen Nephrology has raised a total of $134M across 2 funding rounds.
Evergreen Nephrology's first fundraising round was a $4M seed round in June 2022. The most recent completed round was a $130M undisclosed-stage round in January 2025.
Evergreen Nephrology funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jan 2025 | Undisclosed stage | Oak HC/FT (lead); Rubicon Founders (lead); K2 HealthVentures | $130M | Evergreen Nephrology is a value-based kidney care provider that partners with nephrologists and payors to deliver personalized care for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Operating across 24 states with a network of over 900 providers, the company offers technology-enabled support, interdisciplinary clinical resources, analytical insights, and tools to streamline patient care and address barriers to care transformation. On January 7, 2025, Evergreen Nephrology raised $130 million in a funding round led by Rubicon Founders and Oak HC/FT, with participation from new investor K2 HealthVentures and existing investors. The capital is intended to fuel geographic expansion into new regions, implement advanced technologies to improve clinical outcomes, streamline care delivery, reduce administrative burdens on nephrologists, and support clinical trials. The company's model emphasizes empowering nephrologists through financial backing and resources, shifting kidney care from reactive to proactive strategies while incorporating emotional, spiritual, mental, and social factors for holistic patient treatment. It generates revenue via partnerships, subscription-based services, and performance-based contracts aligned with CMS quality metrics, amid a market where over 37 million Americans have CKD and Medicare spends over $95 billion annually. Prior to this round, total funding reached approximately $134 million. Evergreen, founded in 2021 by Adam Boehler and Abe Sutton and led by CEO John Donlan, continues scaling its provider-integrated strategy with outcomes-based contracts for revenue visibility. |
| Jun 2022 | Seed | - | $4M | Evergreen Nephrology, a Nashville-based provider of value-based kidney care, raised $4.34M in an unattributed VC round on June 6, 2022. Investors included Oak HC/FT Partners and Health2047 Capital Partners. The company partners with nephrologists to deliver whole-person care and advanced analytics tools for patients with chronic kidney disease. Evergreen Nephrology operates across 24 states with a network of more than 900 providers, addressing the needs of over 37 million Americans with chronic kidney disease amid Medicare spending exceeding $95 billion annually. The funding supports expansion into new regions and implementation of advanced technologies to improve clinical outcomes and streamline care delivery. |
Who has invested in Evergreen Nephrology?
3 investors have backed Evergreen Nephrology across its funding rounds, including Oak HC/FT, K2 HealthVentures and Rubicon Founders.
Lead investors include Oak HC/FT and Rubicon Founders.
Evergreen Nephrology Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 1 | Participant | Jan 2025 | ||
This data is available for Pro users. Sign up to see all 3 Evergreen Nephrology investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialEvergreen Nephrology Competitors
Evergreen Nephrology competitors include listed companies like IQVIA and Veeva, and private ones like Cityblock Health, Aledade, Somatus and Strive Health.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $5.7B | - | ||
| Private | $475M | - | $3.5B | 7.4x | ||
| Private | - | - | $2.5B | - | ||
| Private | - | - | $1.8B | - | ||
| Publicly listed | $16B | $3.4B | $44B | 3.4x | ||
| Publicly listed | $3.2B | $965M | $43B | 10.2x |
Evergreen Nephrology Public Comps
Evergreen Nephrology is still privately-owned, but its public comps include UnitedHealth Group, IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, ICON plc, Pro Medicus, United Imaging and Molina Healthcare.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $448B | $23B | 0.9x | 0.9x | 16.7x | 13.3x | |||
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.8x | |||
| $3.2B | $965M | 11.1x | 10.2x | 36.9x | 22.4x | |||
| $4.3B | $1.5B | 9.5x | 8.9x | 27.1x | 24.9x | |||
| $7.9B | $3.2B | 6.1x | 5.7x | 15.2x | 14.6x | |||
| $21B | $3.7B | 1.8x | 1.8x | 10.1x | 10.0x | |||
| $8.3B | $816M | 1.9x | 1.9x | 19.2x | 11.3x | |||
| $186M | $147M | 66.6x | 62.7x | 84.4x | 77.6x | |||
This data is available for Pro users. Sign up to see all Evergreen Nephrology competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Evergreen Nephrology
| When was Evergreen Nephrology founded? | Evergreen Nephrology was founded in 2021. |
| Where is Evergreen Nephrology headquartered? | Evergreen Nephrology is headquartered in Nashville, TN, United States. |
| Is Evergreen Nephrology publicly listed? | No, Evergreen Nephrology is a private, VC-backed company. |
| How much funding has Evergreen Nephrology raised? | Evergreen Nephrology has raised $134M across 2 funding rounds. |
| What was Evergreen Nephrology's last funding round? | Evergreen Nephrology's last funding round was a $130M undisclosed-stage round in January 2025, led by Oak HC/FT and Rubicon Founders. |
| Who are Evergreen Nephrology's investors? | Evergreen Nephrology's investors include K2 HealthVentures, Oak HC/FT and Rubicon Founders. |
| Which companies are comparable to Evergreen Nephrology? | Companies comparable to Evergreen Nephrology include Cityblock Health, Aledade, Somatus, Strive Health, IQVIA and Veeva. |
See companies similar to Evergreen Nephrology
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




